Scilex Holding Co cash flow statement
In fiscal 2025, Scilex Holding Co's operations generated $3.8m of cash; it spent $133,000 on capital projects, leaving free cash flow of $3.7m.
Cash flow statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | −31 | −29 | −21 | −21 | 19 | 4 | −17 |
| Depreciation and amortisation | 4 | 4 | 4 | 4 | 4 | 5 | 5 |
| Stock-based pay | 5 | 6 | 5 | 15 | 16 | 15 | 16 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Free cash flow | −31 | −29 | −21 | −21 | 19 | 4 | — |
| Free cash flow after stock pay | −37 | −34 | −27 | −35 | 4 | −12 | — |
| Dividends paid | — | — | — | 9 | 9 | — | — |
| Shares issued | — | 0 | 0 | 35 | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 5 | 3 | 6 | 7 | 8 | −17 | −1 | −7 |
| Depreciation and amortisation | 0 | 1 | 1 | 0 | 0 | 2 | 3 | 1 |
| Stock-based pay | 4 | 5 | 3 | 3 | 3 | 6 | 4 | 4 |
| Capital spending | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | 5 | 3 | — | 7 | 8 | −17 | −1 | −7 |
| Free cash flow after stock pay | 1 | −2 | — | 4 | 5 | −23 | −5 | −10 |
| Shares issued | 0 | — | — | — | — | — | — | — |
Compare with peers
- Verrica Pharmaceuticals Inc. cash flow
- Sunshine Biopharma Inc. cash flow
- Jaguar Health, Inc. cash flow
- BGM Group Ltd. cash flow
- IM Cannabis Corp. cash flow
Head to head: SCLX vs VRCASBFM vs SCLXJAGX vs SCLX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies